Limitations and challenges

The critical race against cellular decay

Every minute between your heart stopping and your brain reaching cryogenic temperatures is measurable, irreversible damage. Cryopreservation is a race against biochemistry, and biochemistry does not wait.

People imagine cryopreservation as a clean switch flipped from life to preservation. The reality is messier and more urgent. Between the moment your heart stops and the moment your brain reaches a temperature where molecular motion effectively ceases, a cascade of destructive chemistry is running, and it does not pause to be polite. This is the constraint that shapes everything else about the procedure: we are in a race against biochemistry, and biochemistry does not wait. Understanding that race is the key to understanding both what cryopreservation can do and where its hardest limits lie.

a large stopwatch in the foreground racing beside a stylized brain, a downward arrow of time pressure, urgent but clean
Preservation quality is mostly decided in the first hour, a race against biochemistry.

What happens when blood stops flowing

Your brain is metabolically expensive. It is about 2% of your body weight but burns roughly 20% of your oxygen, spending energy constantly just to hold its cells in working order. When circulation stops, that energy supply vanishes almost at once, and the decline begins in stages. Within seconds, oxygen runs out and neurons stop firing. Within minutes, they exhaust their energy reserves and the pumps that maintain their electrical balance fail, releasing a flood of neurotransmitters that can damage neighboring cells, while an emergency metabolism acidifies the tissue, calcium pours in where it should not, and enzymes that dismantle cellular components are switched loose. Within tens of minutes to hours, depending heavily on temperature, the organized architecture of the tissue begins breaking down into molecular disorder.

This, not some abstract notion of death, is what we are racing against: a specific, measurable sequence of events that erases the structure described in memory, identity and the brain. The technical name for the underlying oxygen starvation is ischemia, and it is the central enemy of the first hour.

Temperature is the lever that controls the clock

The single most useful fact here is that the rate of chemical reactions roughly doubles for every 10°C of temperature, and roughly halves for every 10°C you remove. Stack enough of those halvings and the effect is staggering. At body temperature you have minutes before serious damage accumulates. At refrigerator temperature, hours. At dry-ice temperature, days. At the -196°C of liquid nitrogen, you effectively have millennia. This is why every protocol obsesses over cooling the brain as fast as possible: cold is the brake on the entire destructive cascade.

But cooling cannot be reckless. Drop tissue too crudely and you trade one kind of damage for another, including the ice formation the whole procedure is built to avoid. The art is a cooling curve fast enough to outrun decay but controlled enough not to cause fresh harm.

The standby problem

In an ideal case, a trained team is already present at the moment of legal death, cooling begins within seconds, and standby and stabilization flow straight into perfusion. This is exactly what Tomorrow.bio's teams are built to deliver, and it is achievable when death is anticipated, as in hospice. But many deaths are not anticipated. A sudden cardiac arrest, an accident, a death far from a team: each of these inserts hours between death and the start of preservation, and every one of those hours is decay. The standby problem has no perfect solution. We can position teams, educate clinicians, and optimize logistics, but we cannot abolish the gap between an unpredictable death and a prepared response.

Ice is the enemy, and so is the cure

If tissue is allowed to freeze, water crystallizes in the spaces between cells, crushing them against the growing ice and pulling their water out osmotically. This is why modern preservation uses vitrification rather than freezing, turning tissue into a glass-like state through the use of cryoprotectants. But the cure adds its own time pressure: those agents are toxic at the concentrations needed, so they must be introduced gradually, and decay keeps running during that careful ramp. The race includes a sub-race, getting the protectant in before too much damage, but slowly enough to avoid poisoning the tissue. Cryoprotectant toxicity falls steeply as temperature drops, for the same reason the rest of the chemistry does, so perfusion is run close to 0°C: the cold buys tolerance to the agents at the cost of slowing how fast they diffuse into the tissue.

The threshold that actually matters

Not all damage is equal, and this is the most important idea in the whole article. From an information standpoint, there is a difference between damage that obscures the structure and damage that destroys it. A neuron can be battered and non-functional, yet if its connections are still identifiable, the information it held is in principle recoverable. But once a cell is lysed and its connections randomized into unidentifiable debris, the information is gone, and no future technology can recover what randomness has erased. The race against cellular decay is really a race to stop before damage crosses from information-obscuring to information-destroying. We can tolerate a lot of the former. The latter is the only truly irreversible outcome.

The constraints we cannot engineer away

Several hard limits sit on top of the biology, and honesty requires naming them. There is a legal-death paradox: the best moment to begin preservation would be before legal death, but doing so would be homicide, so we must wait, knowing the wait costs fidelity. There is the autopsy problem: some deaths legally require an autopsy first, which both delays preservation and damages the brain. There is geography: even with unlimited resources you cannot have a team instantly everywhere, so where you die shapes how well you can be preserved. None of these are flaws in the science; they are frictions between biological urgency and the legal and physical world, and they mean preservation quality genuinely varies between patients.

Why we run the race anyway

Given all that, why attempt it? Because the alternative guarantees the worst outcome, and the attempt does not. Even preservation under poor conditions, with real ischemic damage, holds more information than burial or cremation, which hold none. A difficult race with an uncertain finish is still worth running when the only other option is not running at all. This is the same lopsided arithmetic as a small chance versus zero, applied to the first hour instead of the far future.

We are racing chemistry and physics. We cannot change the rules of that race, only how well we run it. And for many of us, running it as well as circumstances allow is reason enough to try.

Further reading